Blind studies and therapeutic effects in scleroderma

In this episode of Arthritis At Home, we are featuring the #CRArthritis with Dr. Inés Colmegna, clinician-scientist in the Division of Rheumatology at McGill University. Dr. Colmegna talks about a poster she presented at the Canadian Rheumatology Association’s Annual Scientific Meeting. She explains why blind studies are important in studying the therapeutic effects of scleroderma and shares some key takeaway messages from her poster.Additional learning resourcesScleroderma CanadaArthritis Consumer Experts’ About Scleroderma pageSingle, Double & Triple Blind Study – Definitions and Examples